Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial

por D’Almeida Preto, Daniel, Baston, Mariana Toledo, Geraige, Camilla Centurion, Augusto, Sarah Bertazzi, de Oliveira, Marco Antonio, Mamere, Augusto Elias, Pinto, Gustavo Dix Junqueira, Dias, Josiane Mourão, De Marchi, Pedro Rafael Martins, Paiva, Bianca Sakamoto Ribeiro, Paiva, Carlos Eduardo
Publicado 2019

Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial

por Lim, Sun Min, Peters, Solange, Ortega Granados, Ana Laura, Pinto, Gustavo dix Junqueira, Fuentes, Christian Sebastián, Lo Russo, Giuseppe, Schenker, Michael, Ahn, Jin Seok, Reck, Martin, Szijgyarto, Zsolt, Huseinovic, Neda, Zografos, Eleftherios, Buss, Elena, Stjepanovic, Neda, O’Donnell, Sean, de Marinis, Filippo
Publicado 2023

Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations

por Leal, Letícia Ferro, de Paula, Flávia Escremim, De Marchi, Pedro, de Souza Viana, Luciano, Pinto, Gustavo Dix Junqueira, Carlos, Carolina Dias, Berardinelli, Gustavo Noriz, Miziara, José Elias, da Silva, Carlos Maciel, Silva, Eduardo Caetano Albino, Pereira, Rui, de Oliveira, Marco Antonio, Scapulatempo-Neto, Cristovam, Reis, Rui Manuel
Publicado 2019

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma

por Jacinto, Alexandre Arthur, Batalha Filho, Eronides Salustiano, Viana, Luciano de Souza, De Marchi, Pedro, Capuzzo, Renato de Castro, Gama, Ricardo Ribeiro, Boldrini Junior, Domingos, Santos, Carlos Roberto, Pinto, Gustavo Dix Junqueira, Dias, Josiane Mourão, Canton, Heloisa Pelisser, Carvalho, Raiany, Radicchi, Lucas Augusto, Bentzen, Soren, Zubizarreta, Eduardo, Carvalho, Andre Lopes
Publicado 2018